Chemical Component Summary

NameN-(3-fluoro-4-{[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy}phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide
IdentifiersN-[3-fluoranyl-4-[1-methyl-6-(1H-pyrazol-4-yl)indazol-5-yl]oxy-phenyl]-1-(4-fluorophenyl)-6-methyl-2-oxidanylidene-pyridine-3-carboxamide
FormulaC30 H22 F2 N6 O3
Molecular Weight552.53
TypeNON-POLYMER
Isomeric SMILESCn1ncc2cc(Oc3ccc(NC(=O)C4=CC=C(C)N(C4=O)c5ccc(F)cc5)cc3F)c(cc12)c6c[nH]nc6
InChIInChI=1S/C30H22F2N6O3/c1-17-3-9-23(30(40)38(17)22-7-4-20(31)5-8-22)29(39)36-21-6-10-27(25(32)12-21)41-28-11-18-16-35-37(2)26(18)13-24(28)19-14-33-34-15-19/h3-16H,1-2H3,(H,33,34)(H,36,39)
InChIKeyQHADVLVFMKEIIP-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count63
Chiral Atom Count0
Bond Count68
Aromatic Bond Count27

Drug Info: DrugBank

DrugBank IDDB12381 
NameMerestinib
Groupsinvestigational
DescriptionMerestinib has been used in trials studying the treatment of Cancer, Solid Tumor, Advanced cancer, ColoRectal Cancer, and Metastatic Cancer, among others.
SynonymsMerestinib
Categories
  • Antineoplastic Agents
  • Heterocyclic Compounds, Fused-Ring
  • Nicotinic Acids
  • Protein Kinase Inhibitors
  • Pyrazoles
CAS number1206799-15-6